학술논문
Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial
Document Type
Article
Author
Source
In Diabetes Research and Clinical Practice August 2021 178
Subject
Language
ISSN
0168-8227